ParcelBio

📍 San Francisco, United States🗓 Founded 2023👥 7 employees💰 Last funded Apr 2024
Biotechnology Research🌐 parcelbio.com
Website LinkedIn
ParcelBio is developing a programmable technology to safely and specifically deliver mRNA to diverse cell types in the body. Our proprietary (nanoparticle-free) technology, which we call ‘STAmP’, stabilizes the mRNA and utilizes an interchangeable, lock-and-key-like targeting mechanism which enables fully customizable mRNA medicines.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
2
Frequently asked questions
Who invested in ParcelBio?
ParcelBio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did ParcelBio last raise funding?
The most recent investment in ParcelBio recorded on gritt.io was in April 2024.
When was ParcelBio founded?
ParcelBio was founded in 2023.
What industry is ParcelBio in?
ParcelBio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ParcelBio based?
ParcelBio is headquartered in San Francisco, United States.